Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yingzhou Hong

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Frontiers in Molecular Neuroscience|November 12, 2024
Spatial transcriptomics analysis identifies therapeutic targets in diffuse high-grade gliomasYongtao Yang, Yingzhou Hong, Kai Zhao, et al.
Plos One|June 8, 2026
EP300 promotes bladder cancer cell migration through SNAI2Qing Zhang, Chongjie He, Yingzhou Hong, et al.
Cell Death Discovery|July 27, 2023
The spatiotemporal dynamics of spatially variable genes in developing mouse brain revealed by a novel computational schemeYingzhou Hong, Kai Song, Zongbo Zhang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 8, 2026
Oncogenic epigenetic factor EP300 is a potential therapeutic target for bladder carcinomaQing Zhang, Yingzhou Hong, Chongjie He, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Frontiers in Molecular Neuroscience|November 12, 2024
Spatial transcriptomics analysis identifies therapeutic targets in diffuse high-grade gliomasYongtao Yang, Yingzhou Hong, Kai Zhao, et al.
Plos One|June 8, 2026
EP300 promotes bladder cancer cell migration through SNAI2Qing Zhang, Chongjie He, Yingzhou Hong, et al.
Cell Death Discovery|July 27, 2023
The spatiotemporal dynamics of spatially variable genes in developing mouse brain revealed by a novel computational schemeYingzhou Hong, Kai Song, Zongbo Zhang, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 8, 2026
Oncogenic epigenetic factor EP300 is a potential therapeutic target for bladder carcinomaQing Zhang, Yingzhou Hong, Chongjie He, et al.
Pageof 1